Electron beam (e-beam) modified poly(lactic acid) (PLA) as a biodegradable alternative to conventional plastic food packaging. The process simultaneously sterilizes the material and enhances biodegradability through controlled crosslinking, offering a faster production workflow and improved end-of-life decomposition compared to recyclable plastics with limited cycle life.
This solution addresses the growing challenge of plastic waste in food packaging by offering an alternative material based on electron beam (e-beam) modified poly(lactic acid) (PLA). Conventional recyclable plastics have a limited number of reuse cycles before phase separation renders them unusable, contributing to landfill accumulation. E-beam processing of PLA delivers two simultaneous benefits: in-line sterilization of the packaging material, which shortens production timelines, and enhanced biodegradability once the packaging is discarded. PLA degrades by hydrolysis, where moisture breaks the ester bonds between monomers over months, with lower molecular weight variants degrading faster than higher molecular weight versions.
The technology is at an advanced research stage. Published 2021 work has validated the radical-based crosslinking mechanism and established the effective e-beam dosage range using electron paramagnetic resonance spectrometry. Current efforts are extending the platform by testing copolymer blends and surface or bulk modifications to further improve hydrophilicity, degradability, and elongation at break. The solution is ready for collaborative development toward pilot-scale packaging applications and further validation of permeability, oxygen transmission, and biodegradation performance.
The University of Maryland is the state's flagship public research university in College Park, serving a large student body and offering comprehensive academic and research programs. Industry engages through an adjacent research park, shared prototyping facilities, and dedicated corporate partnership channels, plus joint pathways to a medical campus for clinical and regulatory engagement. Its Washington–Baltimore location places partners near federal agencies, national labs, and prime contractors, while a statewide extension network supports collaboration with companies. Research is backed by competitive federal funding from agencies such as NSF, NIH, DoD, DOE, NASA, and USDA, and coordinated commercialization services advance IP, startup formation, licensing, and industry-sponsored research.